IV immunoglobulin in patients with myasthenia gravis
- 13 March 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 68 (11), 837-841
- https://doi.org/10.1212/01.wnl.0000256698.69121.45
Abstract
Objective: We aimed to determine the effectiveness of IV immunoglobulin (IVIG) in the treatment of patients with myasthenia gravis (MG) and worsening weakness in a randomized, placebo-controlled, masked study. Methods: Fifty-one patients with worsening weakness due to MG were randomized to infusion with 2 g/kg of IVIG or an equivalent volume of IV dextrose 5% in water. The Quantitative Myasthenia Gravis (QMG) Score for Disease Severity, a validated clinical composite scale, was calculated by a masked observer at baseline and days 14 and 28. Results: In IVIG-treated patients, a clinically meaningful improvement in QMG Score for Disease Severity was observed at day 14 and persisted at day 28. The greatest improvement occurred in patients with more severe disease as defined by a QMG Score for Disease Severity greater than 10.5. Conclusion: This study provides level 1 evidence for the effectiveness of IV immunoglobulin in patients with worsening weakness due to myasthenia gravis.Keywords
This publication has 19 references indexed in Scilit:
- Quantitative myasthenia gravis score: Assessment of responsiveness and longitudinal validityNeurology, 2005
- Development of a Thymectomy Trial in Nonthymomatous Myasthenia Gravis Patients Receiving Immunosuppressive TherapyAnnals of the New York Academy of Sciences, 2003
- Insulin Resistance and Insulin-Like Growth Factors in Children with Intrauterine Growth RetardationHormone Research in Paediatrics, 2001
- Myasthenia gravis: recommendations for clinical research standards1The Annals of Thoracic Surgery, 2000
- Plasma Exchange and Intravenous Immunoglobulin in Autoimmune Myasthenia GravisaAnnals of the New York Academy of Sciences, 1998
- Reliability Testing of the Quantitative Myasthenia Gravis ScoreaAnnals of the New York Academy of Sciences, 1998
- A Clinical Therapeutic Trial of Cyclosporine in Myasthenia GravisaAnnals of the New York Academy of Sciences, 1993
- Single fiber EMG reference values: A collaborative effortMuscle & Nerve, 1992
- Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia GravisNew England Journal of Medicine, 1987
- Functional Activities of Autoantibodies to Acetylcholine Receptors and the Clinical Severity of Myasthenia GravisNew England Journal of Medicine, 1982